this agent shares neurochemical effects of known antipsychotic agents in its ability to antagonize cerebral dopamine action by competing for ( 3h ) -haloperidol binding of the dopamine receptors and inhibiting limbic and striatal adenylate cyclase in rat brain .
C0040615
antipsychotic agents
C0018546
haloperidol